Effect of Tri- vs Quadrivalent Flu Vaccination on Mortality, COPD Exacerbation and VTE, Review of Crohn Disease, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 5, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 5, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Crohn's disease: The Lancet: March 1, 2017
Subra Kugathasan discusses his Article which creates a risk-stratification model to predict the risk of developing complications in paediatric patients with newly diagnosed Crohn ’s disease. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 2, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts

RBC storage duration, stem cell transplantation for Crohn disease, management of Graves disease, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 15, 2015 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - December 15, 2015 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients
A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 2, 2015 Category: Gastroenterology Authors: AGA Source Type: podcasts

TWiV 323: A skid loader full of viromes
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Kathy Spindler The family TWiVidae discuss changes in the human fecal virome associated with Crohn's disease and ulcerative colitis. Links for this episode Enteric virome changes in inflammatory bowel disease (Cell) Gov. Christie stumbles on vaccination (NY Times) Anti-vax psychology (NPR) Vaccine skeptic changes her mind (NPR) Ebolavirus sitrep (WHO) Letters read on TWiV 323 Weekly Science Picks Alan - SitesuckerRich - Snake picked wrong dinnerDickson ...
Source: This Week in Virology - MP3 Edition - February 7, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Crohn's disease - a patient's perspective
The incidence and prevalence of Crohn’s disease is increasing worldwide, and a clinical review on thebmj.com provides a practical approach to the diagnosis, management, and long term care of patients with Crohn’s disease. To help us understand what it’s like to have this condition, we're joined by Sarah, who was diagnosed with Crohn’s 13 years... (Source: The BMJ Podcast)
Source: The BMJ Podcast - November 20, 2014 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts

The Debut of Vedolizumab for Inflammatory Bowel Disease
Dr. David Johnson discusses the newly approved drug for both ulcerative colitis and Crohn disease that more closely targets gut inflammation, and may be a boon for patients. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - July 31, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

A Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy
A phase 2 study in the January 2014 issue of CGH investigated the efficacy of allogeneic mesenchymal stromal cells in patients with luminal Crohn's disease. Dr. Kuemmerle speaks with author Dr. Geoffrey M. Forbes (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 14, 2014 Category: Gastroenterology Authors: AGA Source Type: podcasts

Trials of vitamins for HIV progression, thalidomide for pediatric Crohn disease, induced hypothermia for bacterial meningitis, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 27, 2013 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 26, 2013 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Cost-Effective Treatment for Crohn's Disease Patients Who Lose Responsiveness to Infliximab
A study in the June issue of CGH looks at whether a test-based or empiric dose-escalation strategy is more cost-effective for treating Crohn's disease patients who have stopped responding to Infliximab. Dr. Kuemmerle speaks to Dr. Fernando S. Velayos. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 4, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts

Reassessing the Risks and Benefits of Thiopurines in Crohn's Disease
An editorial in the April issue of CGH takes a new look at the risks and benefits of thiopurines in treating Crohn's disease. Dr. Kuemmerle speaks to Dr. Stephen B. Hanauer of the University of Chicago Medical Center (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 4, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts